Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
It improves insulin sensitivity, reduces hepatic glucose production, and has a favourable safety profile with low hypoglycaemia risk
Five agonists that provide GLP-1 and glucagon receptor activity are in phase I/II of clinical development, of which only cotadutide and SAR425899 have shown substantial glycaemic efficacy
Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach
[3] Especificaciones tcnicas DCI Retatrutide Cdigo de desarrollo LY3437943 Clase Agonista triple del receptor de glucagn, GIP y GLP-1 (39 aminocidos) Dianas GCGR, GIPR, GLP-1R Peso molecular 4731 g/mol Frmula molecular No disponible Longitud de secuencia 39 aa Nmero CAS 2381089-83-2 Semivida 6 das en humano Presentacin Vial liofilizado, tapn de bromobutilo, sello de aluminio Actualizado 2026-07-29 Pureza HPLC y COA Especificacin de pureza: 99.0 % (HPLC)
D.CorreiaJ
GCGR/GLP-1R agonist: OR: 0.23, 95%CI: 0.070.75, P = 0.02
